Clinical Trials Browser

Carcinoma, Neuroendocrine × lutetium Lu 177 dotatate × NET × Clear all

NCT02754297 2024-08-21

P-PRRT

Phase 2 Active not recruiting

Carcinoid Tumor, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT04525638 2022-08-02

A Clinical Study to Assess the Combination of Two Drugs (177Lu-DOTATATE and Nivolumab) in Neuroendocrine Tumours

Phase 2 Unknown

Carcinoma, Neuroendocrine, Neuroendocrine Tumors